Publication | Closed Access

Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute mycardial infarction receiving thrombolytic therapy

ThrombosisBeta-adrenergic Blocking AgentCardiovascular DiseaseThrombolytic TherapyAcute Mycardial InfarctionCardiovascular PharmacologyCardiologyPharmacotherapyAcute Myocardial InfarctionPlatelet AntagonistMedicineAnticoagulantAtherosclerosisEmergency MedicineAnesthesiologyMyocardial Infarction